Evidence map›Paper›PMID 26926643›Full record

ArticleAntimicrobial agents and chemotherapy2016

Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans Model.

Alix Pantel, Catherine Dunyach-Remy, Christelle Ngba Essebe, Jennifer Mesureur, Albert Sotto, Jean-Marie Pagès, Marie-Hélène Nicolas-Chanoine, Jean-Philippe Lavigne

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. A review of the mechanisms that confer antibiotic resistance in pathotypes ofFrontiers in cellular and infection microbiology · 2024
    Review
  4. Emergence of theMicrobiology spectrum · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Regulation of Innate Immune Response to Fungal Infection inJournal of microbiology and biotechnology · 2020
    Article
  10. Clinical microbiology reviews · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alix PantelInstitut National de la Santé et de la Recherche Médicale, U1047, Université de Montpellier, UFR de Médecine, Nîmes, France Service de Microbiologie, CHU Carémeau, Nîmes University Hospital, Nîmes, France.
Catherine Dunyach-RemyInstitut National de la Santé et de la Recherche Médicale, U1047, Université de Montpellier, UFR de Médecine, Nîmes, France.
Christelle Ngba EssebeInstitut National de la Santé et de la Recherche Médicale, U1047, Université de Montpellier, UFR de Médecine, Nîmes, France.
Jennifer MesureurInstitut National de la Santé et de la Recherche Médicale, U1047, Université de Montpellier, UFR de Médecine, Nîmes, France.
Albert SottoInstitut National de la Santé et de la Recherche Médicale, U1047, Université de Montpellier, UFR de Médecine, Nîmes, France Service de Maladies Infectieuses et Tropicales, CHU Carémeau, Nîmes University Hospital, Nîmes, France.
Jean-Marie PagèsTransporteurs Membranaires, Chimiorésistance et Drug Design, Facultés de Médecine et Pharmacie, UMR-MD1, IRBA-Université Aix-Marseille, Marseille, France.ORCID 0000-0001-7092-7977
Marie-Hélène Nicolas-ChanoineService de Microbiologie, Hôpital Beaujon, AP-HP, Clichy, France Faculté de Médecine, Université Paris Diderot, Paris, France INSERM, UMR 1149, Université Paris Diderot, Paris, France.
Jean-Philippe LavigneInstitut National de la Santé et de la Recherche Médicale, U1047, Université de Montpellier, UFR de Médecine, Nîmes, France Service de Microbiologie, CHU Carémeau, Nîmes University Hospital, Nîmes, France jean.philippe.lavigne@chu-nimes.fr.ORCID 0000-0002-9484-0304
Inserm · FRAix-Marseille Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Energy-dependent efflux overexpression and altered outer membrane permeability (influx) can promote multidrug resistance (MDR). The present study clarifies the regulatory pathways that control membrane permeability in the pandemic clone Escherichia coli sequence type 131 (ST131) and evaluates the impact of efflux and influx modulations on biofilm formation, motility, and virulence in the Caenorhabditis elegans model. Mutants of two uropathogenic E. coli (UPEC) strains, MECB5 (ST131; H30-Rx) and CFT073 (ST73), as well as a fecal strain, S250 (ST131; H22), were in vitro selected using continuous subculture in subinhibitory concentrations of ertapenem (ETP), chloramphenicol (CMP), and cefoxitin (FOX). Mutations in genes known to control permeability were shown for the two UPEC strains: MECB5-FOX (deletion of 127 bp in marR; deletion of 1 bp and insertion of an IS1 element in acrR) and CFT073-CMP (a 1-bp deletion causing a premature stop in marR). We also demonstrated that efflux phenotypes in the mutants selected with CMP and FOX were related to the AcrAB-TolC pump, but also to other efflux systems. Alteration of membrane permeability, caused by underexpression of the two major porins, OmpF and OmpC, was shown in MECB5-ETP and mutants selected with FOX. Lastly, our findings suggest that efflux pump-overproducing isolates (CMP mutants) pose a serious threat in terms of virulence (significant reduction in worm median survival) and host colonization. Lack of porins (ETP and FOX mutants) led to a high level of antibiotic resistance in an H30-Rx subclone. Nevertheless, this adaptation created a physiological disadvantage (decreased motility and ability to form biofilm) associated with a low potential for virulence.

Indexed as

AnimalsAnti-Bacterial Agentsbeta-LactamsBiofilmsBiological TransportCaenorhabditis elegansCefoxitinChloramphenicolErtapenemEscherichia coliMutationVirulenceAnti-Bacterial Agentsbeta-LactamsCefoxitinChloramphenicolErtapenem

Identifiers

PMID26926643
PMCPMC4862546
OpenAlexW2291610662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.